Gaush Meditech Ltd — Share Issue/Capital Change 2022

Nov 29, 2022

Hong Kong Public Offering — HK eIPO White Form Service Provider Application Form 香港公開發售[—] 網上白表服務供應商申請表格 Please use this application form if you are a HK eIPO White Form Service Provider and are applying for Hong Kong Offer Shares on behalf of underlying applicants. 倘 閣下為網上白表服務供應商並代表相關申請人申請認購香港發售股份，請使用本申請表格。

==> picture [196 x 34] intentionally omitted <==

Gaush Meditech Ltd 高視醫療科技有限公司

(Incorporated in the Cayman Islands with limited liability) （於開曼群島註冊成立的有限責任公司）

GLOBAL OFFERING 全球發售

Number of Offer Shares under the Global Offering : 13,068,600 Shares (comprising 7,382,000 New Shares being offered by us and 5,686,600 Sale Shares being offered by the Selling Shareholder, subject to the Over-allotment Option) 全球發售項下的發售股份數目 ： 13,068,600股股份（包括我們提呈發售的7,382,000股新股份及售股股東提呈發售的 5,686,600股銷售股份，視乎超額配股權行使與否而定） Number of Hong Kong Offer Shares : 1,307,000 Shares (subject to reallocation) 香港發售股份數目 ： 1,307,000股股份（可予重新分配） Number of International Offer Shares : 11,761,600 Shares (comprising 6,075,000 New Shares being offered by us and 5,686,600 Sale Shares being offered by the Selling Shareholder, subject to reallocation and the Over-allotment Option) 國際發售股份數目 ： 11,761,600股股份（包括我們提呈發售的6,075,000股新股份及售股股東提呈發售的 5,686,600股銷售股份，可予重新分配及視乎超額配股權行使與否而定） Offer Price : HK$51.40 per Share, plus brokerage of 1.0%, SFC transaction levy of 0.0027%, Stock Exchange trading fee of 0.005% and AFRC transaction levy of 0.00015% (payable in full on application in Hong Kong Dollars and subject to refund) 發售價 ： 每股股份51.40港元，另加1.0%經紀佣金、0.0027%證監會交易徵費、0.005%聯交所交易費 及0.00015%會財局交易徵費（須於申請時以港元繳足，多繳款項可予退還） Nominal Value : US$0.0001 per Share 面值 ： 每股股份0.0001美元 Stock code : 2407 股份代號 ： 2407

填寫本申請表格前，請細閱高視醫療科技有限公司（「 本公司 」）日期為2022年11月30日的招股章程（「 招股章程 」）（尤其是 招股章程「如何申請香港發售股份」一節）及刊於本申請表格背面的指引。除非本申請表格另有定義，否則本申請表格所 使用的詞語與招股章程所界定者具相同涵義。

Please read carefully the prospectus of Gaush Meditech Ltd (the ““ Prospectus ”) (in particular, the section on “How to Apply for Hong Kong Offer Shares” in the Prospectus) and the Company ”) dated November 30, 2022 (the guide on the back of this Application Form before completing this Application Form. Terms defined in the Prospectus have the same meaning when used in this Application Form unless defined herein.

香港交易及結算所有限公司、香港聯合交易所有限公司（「 聯交所 」）、香港中央結算有限公司（「 香港結算 」）、香港證券 及期貨事務監察委員會（「 證監會 」）及香港公司註冊處處長對本申請表格的內容概不負責，對其準確性或完整性亦不發表 任何聲明，並明確表示概不就因本申請表格全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責 任。

Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited (the “ Stock Exchange ”), Hong Kong Securities Clearing Company Limited (“ HKSCC ”), the Securities and Futures Commission of Hong Kong (“ SFC ”) and the Registrar of Companies in Hong Kong take no responsibility for the contents of this Application Form, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of this Application Form.

本申請表格、招股章程及招股章程附錄五「送呈香港公司註冊處處長及展示文件－送呈香港公司註冊處處長文件」一節 所列的其他文件，已遵照香港法例第32章《公司（清盤及雜項條文）條例》第342C條的規定，送呈香港公司註冊處處長登 記。證監會及香港公司註冊處處長對任何此等文件的內容概不負責。

A copy of this Application Form, the Prospectus and the other documents specified in the section headed “Documents Delivered to the Registrar of Companies in Hong Kong and on Display — Documents Delivered to the Registrar of Companies in Hong Kong” in Appendix V to the Prospectus have been registered by the Registrar of Companies in Hong Kong as required by Section 342C of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Chapter 32 of the Laws of Hong Kong). The SFC and the Registrar of Companies in Hong Kong take no responsibility as to the contents of any of these documents.

閣下敬請留意招股章程「如何申請香港發售股份」一節「個人資料」一段，當中載有本公司及其香港證券登記處有關個人資 料及遵守香港法例第486章《個人資料（私隱）條例》的政策及措施。

Your attention is drawn to the paragraph headed “Personal Data” in the section “How to Apply for Hong Kong Offer Shares” in the Prospectus which sets out the policies and practices of the Company and its Hong Kong Share Registrar in relation to personal data and compliance with the Personal Data (Privacy) Ordinance (Chapter 486 of the Laws of Hong Kong).

本申請表格或招股章程所載者概不構成出售要約或要約購買的遊說，而在任何作出有關要約、遊說或出售即屬違法的司 法權區內，概不得出售任何發售股份。本申請表格所載資料不得在或向美國（包括其領土及屬地、美國各州及哥倫比亞

Nothing in this Application Form or the Prospectus constitutes an offer to sell or the solicitation of an offer to buy nor shall there be any sale of Offer Shares in any jurisdiction in which such offer, solicitation or sales would be unlawful. The information contained in this Application Form is not for distribution, directly or indirectly, in or into the United States (including its territories and dependencies, any State of the United States and the District of Columbia). These materials do not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States. The Shares mentioned herein have not been, and will not be, registered under the U.S. Securities Act and applicable U.S. state securities laws.

information contained in this Application Form is not for distribution, directly or indirectly, in or into the United States 特區）境內直接或間接分發。該等資料不屬於或組成在美國購買或認購證券的任何要約或遊說的一部分。本申請表格所 (including its territories and dependencies, any State of the United States and the District of Columbia). These materials 述股份並無且不會根據美國證券法及適用之美國州證券法登記。 do not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States. The Shares mentioned herein have not been, and will not be, registered under the U.S. Securities Act and applicable U.S. state securities laws. The Shares may not be offered, sold, pledged or transferred within the United States except pursuant to registration or 除非已進行登記或獲豁免遵守美國證券法及適用之美國州證券法的登記規定，否則不得於美國境內提呈發售、出售、抵 an exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. 押或轉讓股份。證券不會在美國公開發售。發售股份乃(1)根據美國證券法的豁免登記規定僅向合資格機構買家（定義見 No public offering of the securities will be made in the United States. The Offer Shares are being offered and sold (1) 美國證券法第144A條）發售及出售；及(2)在美國境外依據美國證券法S規例以離岸交易方式發售及出售。 solely to qualified institutional buyers as defined in Rule 144A under the U.S. Securities Act pursuant to an exemption from registration under the U.S. Securities Act and (2) outside the United States in offshore transactions in relation to Regulation S under the U.S. Securities Act. This Application Form and the Prospectus may not be forwarded or distributed or reproduced (in whole or in part) in 在任何根據有關司法權區法律不得發送、派發或複製本申請表格及招股章程之司法權區內，本申請表格及招股章程概不 any manner whatsoever in any jurisdiction where such forwarding, distribution or reproduction is not permitted under 得以任何方式發送或派發或複製（全部或部分）。本申請表格及招股章程僅致予 閣下本人。概不得發送或派發或複製本 the law of that jurisdiction. This Application Form and the Prospectus are addressed to you personally. Any forwarding 申請表格或招股章程的全部或部分。如未能遵守此項指令，可能導致違反美國證券法或其他司法權區的適用法律。 or distribution or reproduction of this Application Form or the Prospectus in whole or in part is unauthorised. Failure to comply with this directive may result in a violation of the U.S. Securities Act or the applicable laws of other jurisdictions. The allocation of the Offer Shares between the Hong Kong Public Offering and the International Offering will be 在香港公開發售與國際發售之間分配發售股份將受招股章程「全球發售的架構－香港公開發售－重新分配」一節所述調整 subject to adjustment as described in the section headed “Structure of the Global Offering — The Hong Kong Public 規限。具體而言，整體協調人可將發售股份由國際發售重新分配至香港公開發售，以滿足根據香港公開發售作出的有效 Offering — Reallocation” in the Prospectus. In particular, the Overall Coordinators may reallocate Offer Shares from 申請。根據聯交所發出的指引信HKEX-GL91-18，倘有關重新分配並非根據上市規則第18項應用指引作出，若干發售股 the International Offering to the Hong Kong Public Offering to satisfy valid applications under the Hong Kong Public 份可由國際發售重新分配至香港公開發售，從而使根據香港公開發售可供認購的發售股份總數將不會超過2,614,000股 Offering. In accordance with Guidance Letter HKEX-GL91-18 issued by the Stock Exchange, if such reallocation is done 發售股份，佔發售股份約20%。 other than pursuant to Practice Note 18 of the Listing Rules, certain Offer Shares may be reallocated to the Hong Kong Public Offering from the International Offering, so that the total number of the Offer Shares available under the Hong Kong Public Offering would not exceed 2,614,000 Offer Shares, representing approximately 20% of the Offer Shares. If the number of Shares validly applied for in the Hong Kong Public Offering represents (i) 15 times or more but less 倘在香港公開發售中有效申請的股份數目等於根據香港公開發售初步可供認購的香港發售股份數目的(i)15倍或以上但少 than 50 times, (ii) 50 times or more but less than 100 times, and (iii) 100 times or more, of the number of Hong Kong 於50倍；(ii)50倍或以上但少於100倍；及(iii)100倍或以上，則根據香港公開發售可供認購的香港發售股份總數將分別增 Offer Shares initially available under the Hong Kong Public Offering, the total number of Hong Kong Offer Shares 至3,920,600股股份（如屬(i)的情況）、5,227,600股股份（如屬(ii)的情況）及6,534,400股股份（如屬(iii)的情況），分別相當 available under the Hong Kong Public Offering will be increased to 3,920,600 (in the case of (i)), 5,227,600 (in the case 於根據全球發售初步可供認購發售股份總數約30%、約40%及約50%（超額配股權獲行使前）。有關重新分配的進一步詳 of (ii)), and 6,534,400 Shares (in the case of (iii)), respectively, representing approximately 30%, approximately 40%, 情於招股章程「全球發售的架構－香港公開發售－重新分配」一段陳述。 and approximately 50% of the total number of Offer Shares initially available under the Global Offering, respectively (before any exercise of the Over-allotment Option). Further details of the reallocation are stated in the paragraph headed “Structure of the Global Offering — The Hong Kong Public Offering — Reallocation” of the Prospectus. To: Gaush Meditech Ltd 致： 高視醫療科技有限公司 Joint Sponsors 聯席保薦人 Overall Coordinators 整體協調人 Joint Global Coordinators 聯席全球協調人 Joint Bookrunners 聯席賬簿管理人 Joint Lead Managers 聯席牽頭經辦人 Hong Kong Underwriters 香港包銷商 1 We confirm that we have (i) complied with the Guidelines for Electronic Public Offerings and the Operational 吾等確認，吾等已(i)遵守《電子公開發售指引》及透過銀行╱股票經紀遞交 網上白表 申請的運作程序以及與吾等就香 Procedures for HK eIPO White Form applications submitted via Banks/Stockbrokers and all applicable laws and 港公開發售提供 網上白表 服務有關的所有適用法例及規例（不論法定或其他）；及(ii)閱讀招股章程及本申請表格所載 regulations (whether statutory or otherwise) in relation to the provision of our HK eIPO White Form services 條款及條件以及申請手續，並同意受其約束。為了代表與本申請有關的每名相關申請人作出申請，吾等： in connection with the Hong Kong Public Offering; and (ii) read the terms and conditions and application procedures set out in the Prospectus and this Application Form and agree to be bound by them. Applying on behalf of each of the underlying applicants to whom this application relates, we: • apply for the number of Hong Kong Offer Shares set out below, on the terms and conditions of the • 按照招股章程及本申請表格的條款及條件，並在 貴公司組織章程細則規限下， 申請 以下數目的香港發售股 Prospectus and this Application Form, and subject to the Articles of Association of the Company; 份； • enclose payment in full for the Hong Kong Offer Shares applied for, including 1.0% brokerage fee, • 夾附 申請認購香港發售股份所需的全數款項（包括1.0%經紀佣金、0.0027%證監會交易徵費，0.005%聯交所交 0.0027% SFC transaction levy, 0.005% Stock Exchange trading fee and 0.00015% AFRC transaction levy; 易費及0.00015%會財局交易徵費）； • confirm that the underlying applicants have undertaken and agreed to accept the Hong Kong Offer Shares • 確認 相關申請人已承諾及同意接納所申請認購的香港發售股份，或該等相關申請人根據本申請獲分配的任何較 applied for, or any lesser number allocated to such underlying applicants on this application; 少數目的香港發售股份； • undertake and confirm that the underlying applicant(s) and the person for whose benefit the underlying • 承諾 及 確認 相關申請人及相關申請人為其利益而提出申請的人士並無申請或承購或表示有意認購或收取或獲配 applicant(s) is/are applying has/have not applied for or taken up, or indicated an interest for, or received 售或分配（包括有條件及╱或暫定），並將不會申請或承購或表示有意認購國際發售的任何發售股份，亦不會以 or been placed or allocated (including conditionally and/or provisionally), and will not apply for or take 其他方式參與國際發售； up, or indicate an interest for, any Offer Shares under the International Offering nor otherwise participate in the International Offering; • understand that these declarations and representations will be relied upon by the Company and the • 明白 貴公司和整體協調人將依賴此等聲明及陳述，以決定是否就本申請配發任何香港發售股份，以及相關申 Overall Coordinators in deciding whether or not to make any allotment of Hong Kong Offer Shares in 請人如作出虛假聲明，可能會遭受檢控； response to this application, and that the underlying applicants may be prosecuted if they made a false declaration; • authorise the Company to place the name(s) of the underlying applicant(s) on the register of members of • 授權 貴公司將相關申請人的姓名╱名稱列入 貴公司股東名冊內，作為任何將配發予相關申請人的香港發售 the Company as the holder(s) of any Hong Kong Offer Shares to be allotted to them, and the Company 股份的持有人，且 貴公司及╱或其代理可根據本申請表格及招股章程所載程序，按相關申請人的申請指示所 and/or its agents to send any Share certificate(s) (where applicable) and/or e-Auto Refund payment 指定地址以普通郵遞方式寄發任何股票（如適用）及╱或電子自動退款指示（如適用）及╱或任何退款支票（如適 instruction(s) (where applicable) and/or any refund cheques (where applicable) by ordinary post at that 用），郵誤風險概由該相關申請人承擔； underlying applicant’s own risk to the address specified in the application instruction of that underlying applicant in accordance with the procedures prescribed in this Application Form and the Prospectus; • request that any e-Auto Refund payment instructions be despatched to the application payment account • 要求 於申請人使用單一銀行賬戶支付申請股款的情況下，將任何電子自動退款指示發送至有關申請之付款賬戶 where the applicants had paid the application monies from a single bank account; 內； • request that any refund cheque(s) be made payable to the underlying applicant(s) (or, in the case of • 要求 任何退款支票以使用多個銀行賬戶支付申請股款的相關申請人（或（如屬聯名申請）排名首位的申請人）為抬 joint applications, the first-named applicant) who had used multiple bank accounts to pay the application 頭人，並根據本申請表格及招股章程所述程序，將任何有關退款支票以普通郵遞方式寄發到申請所列的地址， monies and to send any such refund cheque(s) by ordinary post at that underlying applicant’s own risk 郵誤風險概由該相關申請人承擔； to the address stated on the application in accordance with the procedures prescribed in this Application Form and the Prospectus; • confirm that each underlying applicant has read the terms and conditions and application procedures set • 確認 各相關申請人已閱讀本申請表格、 IPO App 、指定網站 www.hkeipo.hk 及招股章程載列的條款及條件以及 out in this Application Form, in the IPO App , on the designated website at www.hkeipo.hk and in the 申請手續，並同意受其約束； Prospectus, and agrees to be bound by them; • represent, warrant and undertake (a) that the underlying applicant(s) and any persons for whose benefit • 聲明 、 保證 及 承諾 (a)相關申請人及相關申請人為其利益提出申請的人士並不受香港或其他地方之任何適用法律 the underlying applicant(s) is/are applying is not restricted by any applicable laws of Hong Kong or 限制提出本申請、支付任何申請股款或獲配發或接納任何香港發售股份及相關申請人及相關申請人為其利益提 elsewhere from making this application, paying any application monies for, or being allocated or taking 出申請的人士在填寫及提交申請時身處美國境外及屬S規例第902條第(h)(3)段所述的人士，且相關申請人及相 up, any Hong Kong Offer Shares and the underlying applicant(s) and any persons for whose benefit the 關申請人為其利益提出申請的人士會於離岸交易（定義見S規例）中購入香港發售股份；及(b)向相關申請人或由 underlying applicant(s) is/are applying is/are outside the United States when completing and submitting 相關申請人或為其利益而提出本申請的人士配發或申請認購香港發售股份，不會引致 貴公司、聯席保薦人、 the application and is/are a person described in paragraph (h)(3) of Rule 902 of Regulation S and the 整體協調人、聯席全球協調人、聯席賬簿管理人、聯席牽頭經辦人及香港包銷商或彼等各自的高級職員或顧問 underlying applicant(s) and any persons for whose benefit and the underlying applicant(s) is/are applying 須遵從香港以外任何地區的法律或規例（不論是否具法律效力）的任何規定；及 will acquire the Hong Kong Offer Shares in an offshore transaction (within the meaning of Regulation S); and (b) that the allocation of or application for the Hong Kong Offer Shares to the underlying applicant or by underlying applicant or for whose benefit this application is made would not require the Company, the Joint Sponsors, Overall Coordinators, Joint Global Coordinators, Joint Bookrunners, Joint Lead Managers and the Hong Kong Underwriters or their respective officers or advisers to comply with any requirements under any law or regulation (whether or not having the force of law) of any territory outside Hong Kong; and • agree that this application, any acceptance of it and the resulting contract, will be governed by and • 同意 本申請、任何對本申請的接納以及因而訂立的合約，將受香港法例管轄及按其詮釋。 construed in accordance with the laws of Hong Kong. Signature Date 簽名 日期 Name of applicant Capacity 申請人姓名 身份 2 We, on behalf of the Hong Kong Offer Shares on behalf of the underlying applicants whose details are contained in the read-only underlying applicants, Total number of Shares CD-ROM submitted with this Application Form. offer to purchase 股份總數 代表相關申請人提出認購香港發售股份（申請人的詳細資料包含於連同本申請表格遞交的唯讀光碟）。 吾等（代表相關 申請人）要約購買 3

==> picture [57 x 97] intentionally omitted <==

A total of cheque(s) Cheque number(s) 夾附合共 張支票 支票編號 are enclosed for a total sum of HK$ Name of Bank 總金額為 銀行名稱 港元 Please use BLOCK letters 請用 正楷 填寫 Name of HK eIPO White Form Service Provider 網上白表 服務供應商名稱 Chinese name HK eIPO White Form Service Provider ID 中文名稱 網上白表 服務供應商編號 Name of contact person Contact number Fax number 聯絡人士姓名 聯絡電話號碼 傳真號碼 Address For Broker use 此欄供經紀填寫 地址 Lodged by 申請由以下經紀遞交 Broker no. 經紀號碼 Broker’s chop 經紀印鑑

4

For Bank Use 此欄供銀行填寫

Hong Kong Public Offering — HK eIPO White Form Service Provider Application Form 香港公開發售[—] 網上白表服務供應商申請表格 Please use this application form if you are a HK eIPO White Form Service Provider and are applying for Hong Kong Offer Shares on behalf of underlying applicants. 倘 閣下為網上白表服務供應商並代表相關申請人申請認購香港發售股份，請使用本申請表格。

GUIDE TO COMPLETING THIS APPLICATION FORM

References to boxes below are to the numbered boxes on this Application Form.

• 1 Sign and date the application form in Box 1. Only a written signature will be accepted.

The name and the representative capacity of the signatory should also be stated. To apply for Hong Kong Offer Shares using this Application Form, you must be named in the list of HK eIPO White Form Service Providers who may provide HK eIPO White Form services in relation to the Hong Kong Public Offering, which was released by the SFC.

• 2 Put in Box 2 (in figures) the total number of Hong Kong Offer Shares for which you wish to apply on behalf of the underlying applicants.

Applicant details of the underlying applicants on whose behalf you are applying must be contained in one data file in read-only CD-ROM format submitted together with this Application Form.

填寫本申請表格的指引

下文提述的號碼乃本申請表格中各欄的編號。

1 在申請表格欄1簽署及填上日期。僅接受親筆簽名。 簽署人的姓名及代表身份亦必須註明。如要使用本申請表格申請香港發售股份， 閣下必須為 名列證監會公佈的 網上白表 服務供應商名單內可以就香港公開發售提供 網上白表 服務的人士。

• 2 在欄2填上 閣下欲代表相關申請人申請認購的香港發售股份總數（請填寫數字）。

閣下代其作出申請的相關申請人的詳細資料，必須載於連同本申請表格遞交的一個唯讀光碟格 式的資料檔案內。

3 Complete your payment details in Box 3. 3 在欄3填上 閣下付款的詳細資料。 You must state in this box the number of cheque(s) you are enclosing together with this 閣下必須在此欄註明 閣下連同本申請表格夾附的支票數目；並在每張支票的背面註明(i) 閣 Application Form; and you must state on the reverse of each of those cheque(s) (i) your HK 下的 網上白表 服務供應商編號；及(ii)載有相關申請人申請詳細資料的資料檔案的檔案編號。 eIPO White Form Service Provider ID and (ii) the file number of the data file containing application details of the underlying applicant(s). The dollar amount(s) stated in this box must be equal to the amount payable for the total number 此欄所註明的金額必須與就欄2所示申請認購的香港發售股份總數應付的金額相同。 of Hong Kong Offer Shares applied for in Box 2. All cheque(s) and this Application Form together with a sealed envelope containing the 所有支票及本申請表格，連同載有該唯讀光碟的密封信封（如有）必須放進蓋上 閣下公司印章 CD-ROM, if any, must be placed in the envelope bearing your company chop. 的信封內。 For payments by cheque, the cheque must: 如以支票繳付股款，該支票必須： • be in Hong Kong dollars; • 為港元支票； • be drawn on a Hong Kong dollar bank account in Hong Kong; • 以在香港開設的港元銀行賬戶開出； • show your (or your nominee’s) account name; • 顯示 閣下（或 閣下代名人）的賬戶名稱； • be made payable to “ BANK OF CHINA (HONG KONG) NOMINEES LIMITED – • 註明抬頭人為「 中國銀行（香港）代理人有限公司－GAUSH MEDITECH公開發售 」； GAUSH MEDITECH PUBLIC OFFER ”; • be crossed “Account Payee Only”; • 以「只准入抬頭人賬戶」劃線方式開出； • not be post dated; and • 不得為期票；及 • be signed by the authorised signatories of the HK eIPO White Form Service Provider. • 由 網上白表 服務供應商的授權簽署人簽署。 Your application may be rejected if any of these requirements is not met or if the cheque is 倘未能符合任何此等規定或倘支票首次過戶時不獲兌現， 閣下的申請可遭拒絕受理。 dishonoured on its first presentation. It is your responsibility to ensure that details on the cheque(s) submitted correspond with 閣下有責任確保所遞交的支票上的詳細資料與就本申請遞交的唯讀光碟或資料檔案所載的申請 the application details contained in the CD-ROM or data file submitted in respect of this 詳細資料相同。 application. The Company and the Overall Coordinators have full discretion to reject any applications in the 倘出現差異，本公司及整體協調人有絕對酌情權拒絕任何申請。 case of discrepancies. No receipt will be issued for sums paid on application. 申請時繳付的款項將不會獲發收據。 4 Insert your details in Box 4 (using BLOCK letters). 4 在欄4填上 閣下的詳細資料（用正楷填寫）。 You should write the name, ID and address of the HK eIPO White Form Service Provider in 閣下必須在此欄填上 網上白表 服務供應商的名稱、編號及地址。 閣下亦必須填寫 閣下營業 this box. You should also include the name and telephone number of the contact person at your 地點的聯絡人的姓名及電話號碼及（如適用）經紀號碼及加蓋經紀印章。 place of business and where applicable, the Broker No. and Broker’s Chop. Personal Data 個人資料 Personal Information Collection Statement 個人資料收集聲明 The main provisions of the Personal Data (Privacy) Ordinance (Chapter 486 of the Laws of Hong 香港法例第486章《個人資料（私隱）條例》（「 條例 」）的主要條文於1996年12月20日在香港生效。此項 Kong) (the “ Ordinance ”) came into effect in Hong Kong on December 20, 1996. This Personal 個人資料收集聲明是向股份申請人及持有人說明本公司及其香港證券登記處有關個人資料及條例方 Information Collection Statement informs the applicant for and holder of the Shares of the policies 面的政策及措施。 and practices of the Company and its Hong Kong Share Registrar in relation to personal data and the Ordinance. 1. Reasons for the collection of your personal data 1. 收集 閣下個人資料的原因 From time to time it is necessary for applicants for securities or registered holders of securities 證券申請人或證券登記持有人申請證券或將證券轉往其名下，或將名下證券轉讓予他人，或要 to supply their latest correct personal data to the Company or its agents and/or its Hong Kong 求香港證券登記處提供服務時，須不時向本公司或其代理及╱或其香港證券登記處提供其最新 Share Registrar when applying for securities or transferring securities into or out of their names 的準確個人資料。 or in procuring the services of the Hong Kong Share Registrar. Failure to supply the requested data may result in your application for securities being rejected 未能提供所要求的資料可能導致 閣下的證券申請被拒絕或延遲，或本公司及╱或香港證券登 or in delay or inability of the Company and/or the Hong Kong Share Registrar to effect transfers 記處無法落實證券轉讓或提供服務。此舉亦可能妨礙或延遲登記或轉讓 閣下成功申請的香港 or otherwise render their services. It may also prevent or delay registration or transfer of the 發售股份及╱或寄發股票及╱或發送電子自動退款指示及╱或寄發 閣下應得的退款支票。 Hong Kong Offer Shares which you have successfully applied for and/or the despatch of Share certificate(s), and/or the despatch of e-Auto Refund payment instructions, and/or the despatch of refund cheque(s) to which you are entitled. It is important that holders of securities inform the Company and the Hong Kong Share 證券持有人所提供的個人資料如有任何錯誤，須立即通知本公司及香港證券登記處。 Registrar immediately of any inaccuracies in the personal data supplied. 2. Purposes 2. 用途 The personal data of the applicants and the holders of securities may be used, held and/or stored 證券申請人及持有人的個人資料可因應以下用途使用、持有及╱或保存（不論以何種方式）： (by whatever means) for the following purposes: • processing of your application and e-Auto Refund payment instructions/refund cheque, • 處理 閣下的申請及電子自動退款指示╱退款支票（如適用）及核實是否符合本表格及招 where applicable, and verification of compliance with the terms and application procedures 股章程所載條款及申請手續及公佈香港發售股份的分配結果； set out in this form and the Prospectus and announcing results of allocation of the Hong Kong Offer Shares; • enabling compliance with all applicable laws and regulations in Hong Kong and elsewhere; • 以遵守香港及其他地區的所有適用法律及法規； • registering new issues or transfers into or out of the names of holders of securities • 以證券持有人（包括以香港結算代理人（如適用））的名義登記新發行證券或受讓或轉讓證 including, where applicable, in the name of HKSCC Nominees; 券； • maintaining or updating the registers of holders of securities of the Company; • 存置或更新本公司證券持有人的名冊； • conducting or assisting to conduct signature verifications, any other verification or • 進行或協助進行簽名核對、任何其他核對或交換資料； exchange of information; • establishing benefit entitlements of holders of securities of the Company, such as • 確定本公司證券持有人的受益權利，如股息、供股及紅股等； dividends, rights issues and bonus issues, etc; • distributing communications from the Company and its subsidiaries; • 派發本公司及其附屬公司的公司通訊； • compiling statistical information and Shareholder profiles; • 編製統計資料及股東資料； • making disclosures as required by laws, rules or regulations; • 遵照法例、規則或規例的要求作出披露； • disclosing identities of successful applicants by way of press announcement(s) or • 透過報章公告或其他方式披露獲接納申請人士的身份； otherwise; • disclosing relevant information to facilitate claims on entitlements; and • 披露有關資料以便就權益提出申索；及 • any other incidental or associated purposes relating to the above and/or to enable the • 與上述者有關的任何其他附帶或相關用途及╱或使本公司及香港證券登記處能履行對證 Company and the Hong Kong Share Registrar to discharge their obligations to holders of 券持有人及╱或監管機構承擔的責任及╱或證券持有人不時同意的任何其他用途。 securities and/or regulators and/or any other purpose to which the holders of securities may from time to time agree. 3. Transfer of personal data 3. 轉交個人資料 Personal data held by the Company and the Hong Kong Share Registrar relating to the holders 本公司及香港證券登記處會將證券持有人的個人資料保密，但本公司及其香港證券登記處可在 of securities will be kept confidential but the Company and its Hong Kong Share Registrar may, 將資料用作上述全部或任何用途的必要情況下，作出彼等認為必要之查詢以確定個人資料的準 to the extent necessary for achieving the above purposes or any of them, make such enquiries as 確性，尤其可能會向下列任何及所有人士及機構披露、獲取或轉交證券持有人的個人資料（無 they consider necessary to confirm the accuracy of the personal data and in particular, they may 論在香港境內或境外）： disclose, obtain, transfer (whether within or outside Hong Kong) the personal data of the holders of securities to, from or with any and all of the following persons and entities:

• the Company or its appointed agents such as financial advisers, receiving bankers and overseas principal share registrars;

• where applicants for securities request deposit into CCASS, to HKSCC and HKSCC Nominees, who will use the personal data for the purposes of operating CCASS;

• any agents, contractors or third-party service providers who offer administrative, telecommunications, computer, payment or other services to the Company and/or the Hong Kong Share Registrar in connection with the operation of their respective businesses;

• the Stock Exchange, the SFC and any other statutory, regulatory or governmental bodies; and

• any other persons or institutions with which the holders of securities have or propose to have dealings, such as their bankers, solicitors, accountants or stockbrokers, etc.

4. Retention of personal data

The Company and its Hong Kong Share Registrar will keep the personal data of the applicants and holders of securities for as long as necessary to fulfil the purposes for which the personal data were collected. Personal data which is no longer required will be destroyed or dealt with in accordance with the Ordinance.

5. Access and correction of personal data The Ordinance provides the holders of securities with rights to ascertain whether the Company or the Hong Kong Share Registrar hold their personal data, to obtain a copy of that data, and to correct any data that is inaccurate. In accordance with the Ordinance, the Company and the Hong Kong Share Registrar have the right to charge a reasonable fee for the processing of any data access request. All requests for access to data or correction of data or for information regarding policies and practices and the kinds of data held should be addressed to the Company at its registered office disclosed in the “Corporate Information” section in the Prospectus or as notified from time to time in accordance with applicable law, for the attention of the Company secretary or (as the case may be) the Hong Kong Share Registrar for the attention of the Privacy Compliance Officer for the purposes of the Ordinance.

By signing this form, you agree to all of the above.

DELIVERY OF THIS APPLICATION FORM

This completed Application Form, together with the appropriate cheque(s) and a sealed envelope containing the CD-ROM, must be submitted to the following receiving banks by 4:00 p.m. on Monday, December 5, 2022:

• 本公司或其委任的代理，如財務顧問、收款銀行及海外股份過戶登記總處；

• （如證券申請人要求將證券存於中央結算系統）香港結算或香港結算代理人；彼等將會就 中央結算系統的運作使用有關個人資料；

• 向本公司及╱或香港證券登記處提供與其各自業務運作有關的行政、電訊、電腦、付款 或其他服務的任何代理人、承包商或第三方服務供應商；

• 聯交所、證監會及任何其他法定、監管或政府機關；及

• 證券持有人與其進行或擬進行交易的任何其他人士或機構，如其銀行、律師、會計師或 股票經紀等。

4. 個人資料的保留

• 本公司及其香港證券登記處將按收集個人資料所需的用途保留證券申請人及持有人的個人資 料。毋須保留的個人資料將會根據條例銷毀或處理。

5. 查閱及更正個人資料

條例賦予證券持有人權利以確定本公司或香港證券登記處是否持有其個人資料、索取有關資料 副本及更正任何不準確之資料。根據條例，本公司及香港證券登記處有權就處理任何查閱資料 的要求收取合理費用。所有關於查閱資料或更正資料或查詢有關政策及措施的資料及所持有資 料類別的要求，應按照招股章程「公司資料」一節中披露的本公司註冊辦事處或根據適用法律不 時通知的地址，向本公司的公司秘書或香港證券登記處屬下就條例所指的私隱事務主任（視乎 情況而定）提出。

閣下簽署本表格，即表示同意上述所有規定。

遞交本申請表格

經填妥的本申請表格，連同相關支票及載有唯讀光碟的密封信封，必須於2022年12月5日（星期一） 下午四時正之前，送達下列收款銀行：

中國銀行（香港）有限公司 西九龍 海輝道11號 中銀中心7樓

Bank of China (Hong Kong) Limited 7/F, Bank of China Centre 11 Hoi Fai Road West Kowloon